Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anil Wagh is active.

Publication


Featured researches published by Anil Wagh.


Bioconjugate Chemistry | 2009

Release of Liposomal Contents by Cell-Secreted Matrix Metalloproteinase-9

Jayati Banerjee; Andrea J. Hanson; Bhushan Gadam; Adekunle I. Elegbede; Shakila Tobwala; Bratati Ganguly; Anil Wagh; Wallace W. Muhonen; Benedict Law; John B. Shabb; D. K. Srivastava; Sanku Mallik

Liposomes have been widely used as a drug delivery vehicle, and currently, more than 10 liposomal formulations are approved by the Food and Drug Administration for clinical use. However, upon targeting, the release of the liposome-encapsulated contents is usually slow. We have recently demonstrated that contents from appropriately formulated liposomes can be rapidly released by the cancer-associated enzyme matrix metalloproteinase-9 (MMP-9). Herein, we report our detailed studies to optimize the liposomal formulations. By properly selecting the lipopeptide, the major lipid component, and their relative amounts, we demonstrate that the contents are rapidly released in the presence of cancer-associated levels of recombinant human MMP-9. We observed that the degree of lipid mismatch between the lipopepides and the major lipid component profoundly affects the release profiles from the liposomes. By utilizing the optimized liposomal formulations, we also demonstrate that cancer cells (HT-29) which secrete low levels of MMP-9 failed to release a significant amount of the liposomal contents. Metastatic cancer cells (MCF7) secreting high levels of the enzyme rapidly release the encapsulated contents from the liposomes.


Small | 2013

Polymeric Nanoparticles with Sequential and Multiple FRET Cascade Mechanisms for Multicolor and Multiplexed Imaging

Anil Wagh; Faidat Jyoti; Sanku Mallik; Steven Y. Qian; Estelle Leclerc; Benedict Law

The ability to map multiple biomarkers at the same time has far-reaching biomedical and diagnostic applications. Here, a series of biocompatible poly(D,L-lactic-co-glycolic acid) and polyethylene glycol particles for multicolor and multiplexed imaging are reported. More than 30 particle formulations that exhibit distinct emission signatures (ranging from the visible to NIR wavelength region) are designed and synthesized. These particles are encapsulated with combinations of carbocyanine-based fluorophores DiO, Dil, DiD, and DiR, and are characterized as <100 nm in size and brighter than commercial quantum dots. A particle formulation is identified that simultaneously emits fluorescence at three different wavelengths upon a single excitation at 485 nm via sequential and multiple FRET cascade events for multicolor imaging. Three other particles that display maximum fluorescence intensities at 570, 672, or 777 nm for multiplexed imaging are also identified. These particles are individually conjugated with specific (Herceptin or IgG2A11 antibody) or nonspecific (heptaarginine) ligands for targeting and, thus, could be applied to differentiate different cancer cells from a cell mixture according to the expressions of cell-surface human epidermal growth factor receptor 2 and the receptor for advanced glycation endproducts. Using an animal model subcutaneously implanted with the particles, it is further demonstrated that the developed platform could be useful for in vivo multiplexed imaging.


Nanomedicine: Nanotechnology, Biology and Medicine | 2013

A short circulating peptide nanofiber as a carrier for tumoral delivery.

Anil Wagh; Jagdish Singh; Steven Y. Qian; Benedict Law

UNLABELLED The cellular interactions and in vivo distribution of the nanomaterials are known to be strongly influenced by their physiochemical properties. Here, we investigated and compared the biocompatibility, pharmacokinetics, and biodistribution of previously reported peptide-based nanofiber (NFP), with commercially available nanomaterials. The NFP was a 2-dimensional (2D) structure with an extremely narrow width (4 nm) and a controllable length (50 to 400 nm). NFP was found to be non-toxic, hemocompatible, and with a minimum uptake by macrophages. In vivo studies further demonstrated that NFP could be delivered to the tumor site more effectively, and within a very shorter period of time, than spherical nanoparticles. Importantly, the undelivered NFP was rapidly eliminated by renal clearance and, thus, avoiding its accumulation in the spleen or liver. Overall, our data suggested a new paradigm in drug delivery via using a short circulating NFP, rather than a long circulating 3D nanoparticle, as a delivery cargo. FROM THE CLINICAL EDITOR In this study, the role of small peptide-based nanocarriers is investigated for tumor-specific delivery, reporting excellent targeting properties and a favorable toxicity profile.


ACS Nano | 2012

Linker-Induced Anomalous Emission of Organic-Molecule Conjugated Metal-Oxide Nanoparticles

Volodymyr Turkowski; Suresh Babu; Duy Le; Amit Kumar; Manas K. Haldar; Anil Wagh; Zhongjian Hu; Ajay S. Karakoti; Andre J. Gesquiere; Benedict Law; Sanku Mallik; Talat S. Rahman; Michael N. Leuenberger; Sudipta Seal

Semiconductor nanoparticles conjugated with organic- and dye-molecules to yield high efficiency visible photoluminescence (PL) hold great potential for many future technological applications. We show that folic acid (FA)-conjugated to nanosize TiO(2) and CeO(2) particles demonstrates a dramatic increase of photoemission intensity at wavelengths between 500 and 700 nm when derivatized using aminopropyl trimethoxysilane (APTMS) as spacer-linker molecules between the metal oxide and FA. Using density-functional theory (DFT) and time-dependent DFT calculations we demonstrate that the strong increase of the PL can be explained by electronic transitions between the titania surface oxygen vacancy (OV) states and the low-energy excited states of the FA/APTMS molecule anchored onto the surface oxygen bridge sites in close proximity to the OVs. We suggest this scenario to be a universal feature for a wide class of metal oxide nanoparticles, including nanoceria, possessing a similar band gap (∼3 eV) and with a large surface-vacancy-related density of electronic states. We demonstrate that the molecule-nanoparticle linker can play a crucial role in tuning the electronic and optical properties of nanosystems by bringing optically active parts of the molecule and of the surface close to each other.


The International Journal of Biochemistry & Cell Biology | 2014

The receptor for advanced glycation end products influences the expression of its S100 protein ligands in melanoma tumors.

Varsha Meghnani; Anil Wagh; Venkata S.K. Indurthi; Mohit Koladia; Stefan W. Vetter; Benedict Law; Estelle Leclerc

Recent studies have suggested that the receptor for advanced glycation end products (RAGE) participates in melanoma progression by promoting tumor growth. However, the mechanisms of RAGE activation in melanoma tumors are not clearly understood. To get deeper insights into these mechanisms, we transfected a melanoma cell line, which was established from a human melanoma primary tumor, with RAGE, and studied the effect of RAGE overexpression on cell proliferation and migration in vitro. We observed that overexpression of RAGE in these cells not only resulted in significantly increased migration rates compared to control cells, but also in decreased proliferation rates (Meghnani et al., 2014). In the present study, we compared the growth of xenograft tumors established from RAGE overexpressing WM115 cells, to that of control cells. We observed that when implanted in mice, RAGE overexpressing cells generated tumors faster than control cells. Analysis of protein tumor extracts showed increased levels of the RAGE ligands S100B, S100A2, S100A4, S100A6 and S100A10 in RAGE overexpressing tumors compared to control tumors. We show that the tumor growth was significantly reduced when the mice were treated with anti-RAGE antibodies, suggesting that RAGE, and probably several S100 proteins, were involved in tumor growth. We further demonstrate that the anti-RAGE antibody treatment significantly enhanced the efficacy of the alkylating drug dacarbazine in reducing the growth rate of RAGE overexpressing tumors.


Methods of Molecular Biology | 2013

Methods for conjugating antibodies to nanocarriers.

Anil Wagh; Benedict Law

Antibodies are one of the most commonly used targeting ligands for nanocarriers, mainly because they are specific, have a strong binding affinity, and are available for a number of disease biomarkers. The bioconjugation chemistry can be a crucial factor in determining the targeting efficiency of drug delivery and should be chosen on a case-by-case basis. An antibody consists of a number of functional groups which offer many flexible options for bioconjugation. This chapter focuses on discussing some of the approaches including periodate oxidation, carbodiimide, maleimide, and heterofunctional linkers, for conjugating antibodies to different nanocarriers. The advantages and limitations are described herein. Specific examples are selected to demonstrate the experimental procedures and to illustrate the potential for applying to other nanocarrier system.


Analyst | 2012

Fluorescent polymer-based post-translational differentiation and subtyping of breast cancer cells

Michael D. Scott; Rinku Dutta; Manas K. Haldar; Anil Wagh; Thomas R. Gustad; Benedict Law; Daniel L. Friesner; Sanku Mallik

Herein, we report the application of synthesized fluorescent, water soluble polymers for post-translational subtyping and differentiation of breast cancer cells in vitro. The fluorescence emission spectra from these polymers were modulated differently in the presence of conditioned cell culture media from various breast cancer cells. These polymers differentiate at a post-translation level possibly due to their ability to interact with extracellular enzymes that are over-expressed in cancerous conditions.


Bioconjugate Chemistry | 2012

Development of biocompatible polymeric nanoparticles for in vivo NIR and FRET imaging.

Anil Wagh; Steven Y. Qian; Benedict Law


Chemical Communications | 2010

Liposome-mediated amplified detection of cell-secreted matrix metalloproteinase-9

Jayati Banerjee; Andrea J. Hanson; Erin K. Nyren-Erickson; Bratati Ganguli; Anil Wagh; Wallace W. Muhonen; Benedict Law; John B. Shabb; D. K. Srivastava; Sanku Mallik


Journal of Nanoparticle Research | 2013

A single-layer peptide nanofiber for enhancing the cytotoxicity of trastuzumab (anti-HER)

Ruchi Malik; Anil Wagh; Steven Y. Qian; Benedict Law

Collaboration


Dive into the Anil Wagh's collaboration.

Top Co-Authors

Avatar

Benedict Law

North Dakota State University

View shared research outputs
Top Co-Authors

Avatar

Sanku Mallik

North Dakota State University

View shared research outputs
Top Co-Authors

Avatar

Steven Y. Qian

North Dakota State University

View shared research outputs
Top Co-Authors

Avatar

Andrea J. Hanson

North Dakota State University

View shared research outputs
Top Co-Authors

Avatar

D. K. Srivastava

North Dakota State University

View shared research outputs
Top Co-Authors

Avatar

Estelle Leclerc

North Dakota State University

View shared research outputs
Top Co-Authors

Avatar

Jayati Banerjee

North Dakota State University

View shared research outputs
Top Co-Authors

Avatar

John B. Shabb

University of North Dakota

View shared research outputs
Top Co-Authors

Avatar

Manas K. Haldar

North Dakota State University

View shared research outputs
Top Co-Authors

Avatar

Ruchi Malik

North Dakota State University

View shared research outputs
Researchain Logo
Decentralizing Knowledge